Skip to main content
Erschienen in: Clinical Rheumatology 9/2012

01.09.2012 | Case Based Review

Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein

verfasst von: A. Laria, A. Zoli, M. Bocci, F. Castri, F. Federico, G. F. Ferraccioli

Erschienen in: Clinical Rheumatology | Ausgabe 9/2012

Einloggen, um Zugang zu erhalten

Abstract

Giant cell arteritis (GCA) is a vasculitis of large- vessels. A markedly elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels are characteristics of GCA, although temporal artery biopsy remains the gold standard for the diagnosis. We describe a case of biopsy-proven GCA showing a heavy infiltration of CD68 macrophages and CD3 T cells and with normal ESR and CRP levels at diagnosis.
Key points
(1) GCA may occur with normal ESR in a percentage of about 4 to 15 % (although the American College of Rheumatology classification criteria for giant cell arteritis include an ESR of 50 mm/h or more), while it can occur with normal ESR and normal CRP in a percentage of about 0.8 %. So, the clinical suspicion must be confirmed with a positive biopsy.
(2) GCA patients with ESR >40 mm/h are characterized by higher incidence of headache and jaw claudication compared to patients with normal ESR. In our case, it occurred with normal ESR.
(3) Color duplex ultrasonography is a noninvasive, easy, and inexpensive method for supporting a diagnosis of TA, with a high sensitivity and specificity. It can predict which patient will need TAB.
Literatur
1.
Zurück zum Zitat Smetana GW, Shmerling RH (2002) Does this patient have temporal arteritis? JAMA 287(1):92–101PubMedCrossRef Smetana GW, Shmerling RH (2002) Does this patient have temporal arteritis? JAMA 287(1):92–101PubMedCrossRef
2.
Zurück zum Zitat Salvarani C, Hunder GG (2001) Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study. Arthritis Care Res 45:140CrossRef Salvarani C, Hunder GG (2001) Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study. Arthritis Care Res 45:140CrossRef
3.
Zurück zum Zitat Hunder GG (2006) The early history of giant cell arteritis and polymyalgia rheumatica. First descriptions to 1970. Mayo Clin Proc 81(8):1071–1083PubMedCrossRef Hunder GG (2006) The early history of giant cell arteritis and polymyalgia rheumatica. First descriptions to 1970. Mayo Clin Proc 81(8):1071–1083PubMedCrossRef
4.
Zurück zum Zitat Hellmann DB (2004) Giant cell arteritis and polymyalgia rheumatica. In: Imboden JB, Hellmann DB, Stone JH (eds) Current rheumatology diagnosis and treatment. McGraw Hill, New York, pp 235–241 Hellmann DB (2004) Giant cell arteritis and polymyalgia rheumatica. In: Imboden JB, Hellmann DB, Stone JH (eds) Current rheumatology diagnosis and treatment. McGraw Hill, New York, pp 235–241
5.
Zurück zum Zitat Hunder GG, Bloch DA, Michel BA, Stevens MB et al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122–1128PubMedCrossRef Hunder GG, Bloch DA, Michel BA, Stevens MB et al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122–1128PubMedCrossRef
6.
Zurück zum Zitat Bhatti MT, Tabandeh H (2001) Giant cell arteritis: diagnosis and management. Curr Opin Ophthalmol 12:393–399PubMedCrossRef Bhatti MT, Tabandeh H (2001) Giant cell arteritis: diagnosis and management. Curr Opin Ophthalmol 12:393–399PubMedCrossRef
7.
Zurück zum Zitat Ezeonyeji Amara N, Borg Frances A, Dasgupta Bhaskar (2011) Delays in recognition and management of giant cell arteritis:results from a retrospective audit. Clin Rheumatol 30:259–262PubMedCrossRef Ezeonyeji Amara N, Borg Frances A, Dasgupta Bhaskar (2011) Delays in recognition and management of giant cell arteritis:results from a retrospective audit. Clin Rheumatol 30:259–262PubMedCrossRef
8.
Zurück zum Zitat Weyand CM, Goronzy JJ (2003) Giant cell arteritis and polymalgia rheumatic. Ann Intern Med 139:505–515PubMed Weyand CM, Goronzy JJ (2003) Giant cell arteritis and polymalgia rheumatic. Ann Intern Med 139:505–515PubMed
9.
Zurück zum Zitat Hall JK, Volpe NJ, Galetta SL, Liu GT et al (2003) The role of unilateral temporal artery biopsy. Ophthalmology 110(3):543–548PubMedCrossRef Hall JK, Volpe NJ, Galetta SL, Liu GT et al (2003) The role of unilateral temporal artery biopsy. Ophthalmology 110(3):543–548PubMedCrossRef
10.
Zurück zum Zitat Nesher G, Shemesh D, Mates M, Sonnenblick M, Abrmowitz HBJ (2002) The predictive value of the halo sign in color Doppler ultrasonography of the temporal arteries for diagnosing giant cell arteritis. Rheumatol 29(6):1224–1226 Nesher G, Shemesh D, Mates M, Sonnenblick M, Abrmowitz HBJ (2002) The predictive value of the halo sign in color Doppler ultrasonography of the temporal arteries for diagnosing giant cell arteritis. Rheumatol 29(6):1224–1226
11.
Zurück zum Zitat Karahaliou M, Vaiopoulos G, Papaspyrou S, Kankis M, Revenas K, Sfikakis PP (2006) Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis. Arthritis Res Ther 8(4):R116PubMedCrossRef Karahaliou M, Vaiopoulos G, Papaspyrou S, Kankis M, Revenas K, Sfikakis PP (2006) Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis. Arthritis Res Ther 8(4):R116PubMedCrossRef
12.
Zurück zum Zitat Habib Hisham M, Essa Ashraf A, Hassan Ayman A (2012) Color duplex ultrasonography of temporal arteries: role in diagnosis and follow-up of suspected cases of temporal arteritis. Clin Rheumatol 31:231–237PubMedCrossRef Habib Hisham M, Essa Ashraf A, Hassan Ayman A (2012) Color duplex ultrasonography of temporal arteries: role in diagnosis and follow-up of suspected cases of temporal arteritis. Clin Rheumatol 31:231–237PubMedCrossRef
13.
Zurück zum Zitat Wong RL, Korn JH (1986) Temporal arteritis without an elevated erythrocyte sedimentation rate. Case report and review of the literature. Am J Med 80(5):959–964PubMedCrossRef Wong RL, Korn JH (1986) Temporal arteritis without an elevated erythrocyte sedimentation rate. Case report and review of the literature. Am J Med 80(5):959–964PubMedCrossRef
14.
Zurück zum Zitat Myklebust G, Gran JT (1996) A prospective study of 287 patients with polymyalgia rheumatica and temporal arterttis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 35:1161–1168PubMedCrossRef Myklebust G, Gran JT (1996) A prospective study of 287 patients with polymyalgia rheumatica and temporal arterttis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 35:1161–1168PubMedCrossRef
15.
Zurück zum Zitat Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR (1978) Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med 88(2):162–167PubMed Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR (1978) Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med 88(2):162–167PubMed
16.
Zurück zum Zitat Parikh M, Miller NR, Lee AG, Savino PJ, Vacarezza MN, Cornblath W, Eggenberger E, Antonio-Santos A, Golnik K, Kardon R, Wall M (2006) Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology 113(10):1842–1845PubMedCrossRef Parikh M, Miller NR, Lee AG, Savino PJ, Vacarezza MN, Cornblath W, Eggenberger E, Antonio-Santos A, Golnik K, Kardon R, Wall M (2006) Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology 113(10):1842–1845PubMedCrossRef
17.
Zurück zum Zitat Kermani TA, Schmidt J, Crowson CS, Ytterberg SR, Hunder GG, Matteson EL, Warrington KJ (2011) Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum 41(6):866–871PubMedCrossRef Kermani TA, Schmidt J, Crowson CS, Ytterberg SR, Hunder GG, Matteson EL, Warrington KJ (2011) Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum 41(6):866–871PubMedCrossRef
18.
Zurück zum Zitat Weyand CM, Goronzy JJ (1999) Arterial wall injury in giant cell arteritis. Arthritis Rheum 42(5):844–853PubMedCrossRef Weyand CM, Goronzy JJ (1999) Arterial wall injury in giant cell arteritis. Arthritis Rheum 42(5):844–853PubMedCrossRef
19.
Zurück zum Zitat Lopez-Diaz MJ, Llorca J, Gonzalez-Juanatey C, Peña-Sagredo JL, Martin J, Gonzalez-Gay MA (2008) The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis. Semin Arthritis Rheum 38:116–123PubMedCrossRef Lopez-Diaz MJ, Llorca J, Gonzalez-Juanatey C, Peña-Sagredo JL, Martin J, Gonzalez-Gay MA (2008) The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis. Semin Arthritis Rheum 38:116–123PubMedCrossRef
20.
Zurück zum Zitat Cantini F, Salvarani C, Olivieri I (1998) Erythrocyte sedimentation rate and C-reactive protein in the diagnosis of polymyalgia rheumatica. Ann Intern Med 128(10):873–874PubMed Cantini F, Salvarani C, Olivieri I (1998) Erythrocyte sedimentation rate and C-reactive protein in the diagnosis of polymyalgia rheumatica. Ann Intern Med 128(10):873–874PubMed
21.
Zurück zum Zitat Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111(12):1805–1812PubMed Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111(12):1805–1812PubMed
22.
Zurück zum Zitat Szalai AJ, McCrory MA, Cooper GS, Wu J, Kimberly RP (2002) Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene. Genes Immun 3:14–19PubMedCrossRef Szalai AJ, McCrory MA, Cooper GS, Wu J, Kimberly RP (2002) Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene. Genes Immun 3:14–19PubMedCrossRef
23.
Zurück zum Zitat Russell AI, Cunninghame GDS, Shepherd C, Roberton CA, Whittaker J, Meeks J, Powell RJ, Isenberg DA, Walport MJ, Vyse TJ (2004) Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 13(1):137–147PubMedCrossRef Russell AI, Cunninghame GDS, Shepherd C, Roberton CA, Whittaker J, Meeks J, Powell RJ, Isenberg DA, Walport MJ, Vyse TJ (2004) Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 13(1):137–147PubMedCrossRef
24.
Zurück zum Zitat Ellis ME, Ralston S (1983) The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome. Ann Rheum Dis 42:168–170 Ellis ME, Ralston S (1983) The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome. Ann Rheum Dis 42:168–170
25.
Zurück zum Zitat Branum G, Massey EW, Rice J (1987) Erythrocyte sedimentation rate in temporal arteritis. South Med J 80:1527–1528 Branum G, Massey EW, Rice J (1987) Erythrocyte sedimentation rate in temporal arteritis. South Med J 80:1527–1528
26.
Zurück zum Zitat Kyle V, Cawston TE, Hazleman BL (1989) Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis 48:667–671 Kyle V, Cawston TE, Hazleman BL (1989) Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis 48:667–671
27.
Zurück zum Zitat Jundt JW, Mock D (1991) Temporal arteritis with normal erythrocyte sedimentation rates presenting as occipital neuralgia. Arthritis Rheum 34(2):217–219 Jundt JW, Mock D (1991) Temporal arteritis with normal erythrocyte sedimentation rates presenting as occipital neuralgia. Arthritis Rheum 34(2):217–219
28.
Zurück zum Zitat Wise CM, Agudelo CA, Chmelewski WL, McKnight KM (1991) Temporal arteritis with low erythrocyte sedimentation rate: a review of five cases. Arthritis Rheum 34:1571–1574 Wise CM, Agudelo CA, Chmelewski WL, McKnight KM (1991) Temporal arteritis with low erythrocyte sedimentation rate: a review of five cases. Arthritis Rheum 34:1571–1574
29.
Zurück zum Zitat Myklebust G, Gran JT (1996) A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 35:1161–1168 Myklebust G, Gran JT (1996) A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 35:1161–1168
30.
Zurück zum Zitat Olsson AT, Elling H, Elling P (1997) Frequency of a normal erythrocyte sedimentation rate in patients with active,untreated arteritis temporalis and polymyalgia rheumatica: comment on the articleby Helfgott and Kieval. Arthritis Rheum 40:191–3 Olsson AT, Elling H, Elling P (1997) Frequency of a normal erythrocyte sedimentation rate in patients with active,untreated arteritis temporalis and polymyalgia rheumatica: comment on the articleby Helfgott and Kieval. Arthritis Rheum 40:191–3
31.
Zurück zum Zitat von Blotzheim SG, Borruat FX (1996) [Neuro-ophthalmological complications of Horton's disease]. Rev Med Suisse Romande 116:21–25 von Blotzheim SG, Borruat FX (1996) [Neuro-ophthalmological complications of Horton's disease]. Rev Med Suisse Romande 116:21–25
32.
Zurück zum Zitat Martínez-Taboada VM, Blanco R, Armona J, Uriarte E, Figueroa M, Gonzalez-Gay MA, Rodriguez-Valverde V (2000) Giant cell arteritis with an erythrocyte sedimentation rate lower than 50. Clin Rheumatol 19:73–75 Martínez-Taboada VM, Blanco R, Armona J, Uriarte E, Figueroa M, Gonzalez-Gay MA, Rodriguez-Valverde V (2000) Giant cell arteritis with an erythrocyte sedimentation rate lower than 50. Clin Rheumatol 19:73–75
33.
Zurück zum Zitat Pamuk ON, Dönmez S, Karahan B, Pamuk GE, Cakir N (2009) Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data. Clin Exp Rheumatol 27:830–833 Pamuk ON, Dönmez S, Karahan B, Pamuk GE, Cakir N (2009) Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data. Clin Exp Rheumatol 27:830–833
Metadaten
Titel
Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein
verfasst von
A. Laria
A. Zoli
M. Bocci
F. Castri
F. Federico
G. F. Ferraccioli
Publikationsdatum
01.09.2012
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 9/2012
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-012-2031-3

Weitere Artikel der Ausgabe 9/2012

Clinical Rheumatology 9/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.